Impact of sedentarism due to the COVID-19 home confinement on neuromuscular, cardiovascular and metabolic health: Physiological and pathophysiological implications and recommendations for physical and nutritional countermeasures.


Journal

European journal of sport science
ISSN: 1536-7290
Titre abrégé: Eur J Sport Sci
Pays: England
ID NLM: 101146739

Informations de publication

Date de publication:
Apr 2021
Historique:
pubmed: 13 5 2020
medline: 28 5 2021
entrez: 13 5 2020
Statut: ppublish

Résumé

The COVID-19 pandemic is an unprecedented health crisis as entire populations have been asked to self-isolate and live in home-confinement for several weeks to months, which in itself represents a physiological challenge with significant health risks. This paper describes the impact of sedentarism on the human body at the level of the muscular, cardiovascular, metabolic, endocrine and nervous systems and is based on evidence from several models of inactivity, including bed rest, unilateral limb suspension, and step-reduction. Data form these studies show that muscle wasting occurs rapidly, being detectable within two days of inactivity. This loss of muscle mass is associated with fibre denervation, neuromuscular junction damage and upregulation of protein breakdown, but is mostly explained by the suppression of muscle protein synthesis. Inactivity also affects glucose homeostasis as just few days of step reduction or bed rest, reduce insulin sensitivity, principally in muscle. Additionally, aerobic capacity is impaired at all levels of the O

Identifiants

pubmed: 32394816
doi: 10.1080/17461391.2020.1761076
doi:

Substances chimiques

Oxygen S88TT14065

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

614-635

Subventions

Organisme : Medical Research Council
ID : MR/K00414X/1
Pays : United Kingdom

Auteurs

Marco Narici (M)

Department of Biomedical Sciences, CIR-MYO Myology Center, Neuromuscular Physiology Laboratory, University of Padova, Padua, Italy.

Giuseppe De Vito (G)

Department of Biomedical Sciences, CIR-MYO Myology Center, Neuromuscular Physiology Laboratory, University of Padova, Padua, Italy.

Martino Franchi (M)

Department of Biomedical Sciences, Neuromuscular Physiology Laboratory, University of Padova, Padua, Italy.

Antonio Paoli (A)

Department of Biomedical Sciences, Nutrition and Exercise Physiology Laboratory, University of Padova, Padua, Italy.

Tatiana Moro (T)

Department of Biomedical Sciences, Nutrition and Exercise Physiology Laboratory, University of Padova, Padua, Italy.

Giuseppe Marcolin (G)

Department of Biomedical Sciences, Nutrition and Exercise Physiology Laboratory, University of Padova, Padua, Italy.

Bruno Grassi (B)

Department of Medicine, University of Udine, Udine, Italy.

Giovanni Baldassarre (G)

Department of Medicine, University of Udine, Udine, Italy.

Lucrezia Zuccarelli (L)

Department of Medicine, University of Udine, Udine, Italy.

Gianni Biolo (G)

Department of Internal Medicine, University of Trieste, Ospedale di Cattinara, Trieste, Italy.

Filippo Giorgio di Girolamo (FG)

Department of Internal Medicine, University of Trieste, Ospedale di Cattinara, Trieste, Italy.

Nicola Fiotti (N)

Department of Internal Medicine, University of Trieste, Ospedale di Cattinara, Trieste, Italy.

Flemming Dela (F)

Xlab, Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
Department of Geriatrics, Bispebjerg-Frederiksberg University Hospital, Copenhagen, Denmark.

Paul Greenhaff (P)

MRC Versus Arthritis Centre for Musculoskeletal Ageing Research, Centre for Sport, Exercise and Osteoarthritis Research Versus Arthritis, National Institute for Health Research Nottingham Biomedical Research Centre, School of Life Sciences, The Medical School, University of Nottingham, Queen's Medical Centre, Nottingham, UK.

Constantinos Maganaris (C)

School of Sport and Exercise Sciences, Liverpool John Moores University, Liverpool, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH